Ginkgo biloba is a Chinese patent medicine that invigorates blood circulation and dispels blood stasis, the main components are flavonol glycosides and terpene lactones, which are used to treat various symptoms caused by blood stasis and obstruction.
Clinical studies of Ginkgo biloba have confirmed that it can improve the nervous system function of ischemic stroke patients, delay cognitive decline and dementia after stroke, and improve the ability of daily living.
Ginkgo biloba is suitable for ischemic stroke, including the acute, convalescent, and sequelae phases, as well as cognitive dysfunction after stroke.
Although some evidence-based evidence has been obtained for both Naoxintong Capsule and Ginkgo biloba, the current clinical studies generally have shortcomings such as small sample size and insufficient design, and their credibility is limited.
Therefore, Naoxintong Capsule or Ginkgo biloba cannot replace anti-ischemic drugs such as antiplatelet drugs and lipid-regulating drugs, and can only be used in combination with these drugs to enhance the efficacy and be used for the adjuvant treatment of cerebral infarction.
In terms of clinical selection, Naoxintong Capsule and Ginkgo biloba have many similarities, both of which are suitable for symptoms such as stroke, hemiplegia, and limb numbness caused by blood stasis obstruction syndrome.
Ginkgo biloba is an effective Chinese patent medicine, but you need to follow your doctor's advice when using it. If you have any questions or need further assistance, please consult a medical professional. #TCM# #清风计划#
